Tim Sobolevsky

1.0k total citations
31 papers, 827 citations indexed

About

Tim Sobolevsky is a scholar working on Endocrinology, Diabetes and Metabolism, Spectroscopy and Pharmacology. According to data from OpenAlex, Tim Sobolevsky has authored 31 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Spectroscopy and 7 papers in Pharmacology. Recurrent topics in Tim Sobolevsky's work include Hormonal and reproductive studies (13 papers), Mass Spectrometry Techniques and Applications (8 papers) and Analytical Chemistry and Chromatography (7 papers). Tim Sobolevsky is often cited by papers focused on Hormonal and reproductive studies (13 papers), Mass Spectrometry Techniques and Applications (8 papers) and Analytical Chemistry and Chromatography (7 papers). Tim Sobolevsky collaborates with scholars based in United States, Russia and Germany. Tim Sobolevsky's co-authors include Г. М. Родченков, A. I. Revelsky, I. A. Revelsky, Edward Danielevich Virus, Barbara Miller, Brian Ahrens, Elena S. Chernetsova, Barbara Miller, Katja Walpurgis and Matthew Fedoruk and has published in prestigious journals such as Journal of Chromatography A, Clinical Chemistry and Analytical and Bioanalytical Chemistry.

In The Last Decade

Tim Sobolevsky

30 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Sobolevsky United States 14 350 288 221 209 165 31 827
Г. М. Родченков Russia 20 410 1.2× 329 1.1× 252 1.1× 476 2.3× 221 1.3× 56 1.1k
Moon Kyo In South Korea 18 411 1.2× 160 0.6× 197 0.9× 86 0.4× 141 0.9× 47 752
Sara Odoardi Italy 19 684 2.0× 155 0.5× 367 1.7× 130 0.6× 192 1.2× 37 1.1k
Jin Young Kim South Korea 16 342 1.0× 129 0.4× 168 0.8× 96 0.5× 134 0.8× 53 681
Oliver Krug Germany 18 186 0.5× 153 0.5× 156 0.7× 442 2.1× 183 1.1× 40 848
Giampietro Frison Italy 20 482 1.4× 165 0.6× 256 1.2× 62 0.3× 219 1.3× 48 929
Camilla Montesano Italy 22 485 1.4× 214 0.7× 281 1.3× 70 0.3× 271 1.6× 62 1.1k
Ruri Kikura Japan 16 447 1.3× 56 0.2× 160 0.7× 152 0.7× 78 0.5× 20 677
Yan Shi China 18 334 1.0× 73 0.3× 175 0.8× 63 0.3× 267 1.6× 76 796
Thomas Bassindale United Kingdom 10 140 0.4× 111 0.4× 191 0.9× 409 2.0× 126 0.8× 16 729

Countries citing papers authored by Tim Sobolevsky

Since Specialization
Citations

This map shows the geographic impact of Tim Sobolevsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Sobolevsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Sobolevsky more than expected).

Fields of papers citing papers by Tim Sobolevsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Sobolevsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Sobolevsky. The network helps show where Tim Sobolevsky may publish in the future.

Co-authorship network of co-authors of Tim Sobolevsky

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Sobolevsky. A scholar is included among the top collaborators of Tim Sobolevsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Sobolevsky. Tim Sobolevsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sobolevsky, Tim, et al.. (2025). Carbon Isotope Ratio Analysis of Urinary Steroids Following Extensive Cleanup and Formylation. Drug Testing and Analysis. 18(1). 170–186.
2.
Sobolevsky, Tim, Matthew Fedoruk, Frank Dellanna, et al.. (2024). Long‐Term Excretion of Roxadustat in Urine. Drug Testing and Analysis. 17(7). 1088–1092. 2 indexed citations
3.
Sobolevsky, Tim, Katja Walpurgis, Matthew Fedoruk, et al.. (2023). Detection of capromorelin in urine following oral and dermal routes of administration. Drug Testing and Analysis. 15(11-12). 1449–1453. 4 indexed citations
4.
Sobolevsky, Tim, et al.. (2023). Detection of selective androgen receptor modulator YK‐11 in a doping control sample. Drug Testing and Analysis. 16(6). 655–660. 3 indexed citations
5.
Sobolevsky, Tim, Thomas Piper, Brian Ahrens, & Mario Thevis. (2022). AICAr to SAICAr ratio can serve as additional marker of AICAr use. Drug Testing and Analysis. 14(11-12). 2017–2025. 3 indexed citations
6.
7.
Sobolevsky, Tim & Brian Ahrens. (2021). Biotin as a masking agent in chorionic gonadotropin assays utilizing biotinylated antibodies. Drug Testing and Analysis. 13(11-12). 1929–1935. 3 indexed citations
8.
Sobolevsky, Tim & Brian Ahrens. (2020). High‐throughput liquid chromatography tandem mass spectrometry assay as initial testing procedure for analysis of total urinary fraction. Drug Testing and Analysis. 13(2). 283–298. 18 indexed citations
9.
Sobolevsky, Tim, et al.. (2018). Isotopically labeled boldenone as a better marker of derivatization efficiency for improved quality control in anti‐doping analysis. Drug Testing and Analysis. 11(2). 336–340. 2 indexed citations
10.
Sobolevsky, Tim & Brian Ahrens. (2018). Urinary concentrations of AICAR and mannitol in athlete population. Drug Testing and Analysis. 11(3). 530–535. 6 indexed citations
11.
Sobolevsky, Tim, et al.. (2014). Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue. Drug Testing and Analysis. 7(2). 131–142. 28 indexed citations
12.
Sobolevsky, Tim, et al.. (2012). Detection of urinary metabolites of AM‐2201 and UR‐144, two novel synthetic cannabinoids. Drug Testing and Analysis. 4(10). 745–753. 117 indexed citations
13.
Sobolevsky, Tim & Г. М. Родченков. (2011). Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine. The Journal of Steroid Biochemistry and Molecular Biology. 128(3-5). 121–127. 71 indexed citations
14.
Sobolevsky, Tim & Г. М. Родченков. (2010). Sulbutiamine in sports. Drug Testing and Analysis. 2(11-12). 643–646. 4 indexed citations
15.
Sobolevsky, Tim, et al.. (2010). Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Science International. 200(1-3). 141–147. 197 indexed citations
16.
Virus, Edward Danielevich, et al.. (2010). Mass spectrometry of doping preparations of a new generation: Peroxisome proliferator-activated receptor agonists. Journal of Analytical Chemistry. 65(13). 1411–1419. 1 indexed citations
17.
Virus, Edward Danielevich, Tim Sobolevsky, & Г. М. Родченков. (2008). Introduction of HPLC/orbitrap mass spectrometry as screening method for doping control. Journal of Mass Spectrometry. 43(7). 949–957. 57 indexed citations
18.
Chernetsova, Elena S., et al.. (2005). Improving the accuracy of carbon-to-hydrogen ratio determination for P, N, S, O, Cl, and Br-containing organic compounds using atomic emission detection. Analytical and Bioanalytical Chemistry. 382(2). 448–451. 7 indexed citations
19.
Chernetsova, Elena S., et al.. (2005). Increasing the accuracy of determination of nC/nH ratios by gas chromatography–atomic emission detection. Journal of Chromatography A. 1071(1-2). 55–58. 1 indexed citations
20.
Sobolevsky, Tim, Elena S. Chernetsova, A. I. Revelsky, et al.. (2003). Electron Ionization Mass Spectra and Their Reproducibility for Trialkylsilylated Derivatives of Organic Acids, Sugars and Alcohols. European Journal of Mass Spectrometry. 9(5). 487–495. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Г. М. Родченков Breakdown of academic impact, for papers by Moon Kyo In Breakdown of academic impact, for papers by Sara Odoardi Breakdown of academic impact, for papers by Jin Young Kim Breakdown of academic impact, for papers by Oliver Krug Breakdown of academic impact, for papers by Giampietro Frison Breakdown of academic impact, for papers by Camilla Montesano Breakdown of academic impact, for papers by Ruri Kikura Breakdown of academic impact, for papers by Yan Shi Breakdown of academic impact, for papers by Thomas Bassindale
Rankless by CCL
2026